Check out our most popular compounded medications! Get Started
The Hydromorphone HCl 2 mg/ml Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug administration. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills or tablets, such as those in pediatric and geriatric groups. The medication is indicated for the management of pain in patients where an opioid analgesic is appropriate. It is commonly used to treat moderate to severe chronic pain in conditions that are responsive to opioid therapy, such as cancer-related pain, postoperative pain, and certain types of non-malignant chronic pain. The liquid form ensures that patients receive their medication in an accurate dose.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Hydromorphone HCl 2 mg/ml Oral Liquid is a potent opioid analgesic specifically compounded for oral administration. This formulation is designed to provide pain relief for patients who require consistent and controlled analgesia. The liquid form is particularly beneficial for individuals who have difficulty swallowing pills, such as pediatric and geriatric patients, or those with dysphagia. The 2 mg/ml concentration allows for precise dosing tailored to the patient's specific needs.
The medication works by binding to the mu-opioid receptors in the brain and spinal cord, altering the perception of and response to pain. It is commonly used in the treatment of moderate to severe pain that is not responsive to non-opioid analgesics. Hydromorphone is known for its rapid onset of action and relatively short duration of effect, making it a suitable option for both acute and chronic pain management. It is important to note that due to its opioid nature, hydromorphone carries a risk of addiction, abuse, and misuse, which necessitates careful patient selection and monitoring.
The prescriber must monitor for signs of respiratory depression, especially during treatment initiation and dose escalation. Patients and caregivers should be educated on the proper administration, potential side effects, and the importance of adhering to prescribed dosing schedules. Additionally, this medication should be used with caution in patients with renal or hepatic impairment, and dose adjustments may be necessary.
Bayview Pharmacy is committed to ensuring the highest quality of compounded medications. Our team of knowledgeable compounding pharmacists is available to answer any questions and provide guidance on the use of Hydromorphone HCl 2 mg/ml Oral Liquid. We work closely with prescribers to customize formulations to meet the unique needs of each patient. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us.
Hydromorphone HCl is an opioid analgesic used for the relief of moderate to severe pain. As with all opioids, there are significant interactions that must be considered to ensure patient safety and efficacy of the medication. Hydromorphone should be used with caution when co-administered with central nervous system (CNS) depressants such as benzodiazepines, barbiturates, anxiolytics, hypnotics, other opioids, or alcohol. Concurrent use can result in profound sedation, respiratory depression, coma, and death. It is crucial to avoid prescribing these drugs concomitantly unless supervised by a healthcare provider.
Patients taking serotonergic drugs, including SSRIs, SNRIs, MAO inhibitors, triptans, and tricyclic antidepressants, should be monitored for symptoms of serotonin syndrome, a potentially life-threatening condition. If serotonin syndrome is suspected, prompt discontinuation of the serotonergic drug(s) and initiation of symptomatic treatment is necessary.
Hydromorphone may also interact with anticholinergic medications, which can result in increased risk of severe constipation and urinary retention. This is particularly important in the elderly population, where these effects can lead to significant complications. Additionally, the use of antidiarrheal agents that have anticholinergic properties can exacerbate these effects.
Patients receiving MAO inhibitors or those who have received them within the past 14 days may experience unpredictable, severe, and potentially fatal reactions with hydromorphone. The combination can lead to hypertensive crisis, hyperpyrexia, and serotonin syndrome. Extreme caution is advised, and a washout period of 14 days should be observed before initiating hydromorphone therapy.
Hydromorphone's metabolism may be altered by drugs that affect the cytochrome P450 3A4 enzyme system. Inhibitors of this enzyme, such as macrolide antibiotics (e.g., erythromycin), azole antifungal agents (e.g., ketoconazole), and protease inhibitors (e.g., ritonavir), can lead to an increase in hydromorphone plasma concentrations, which may enhance or prolong both therapeutic and adverse effects. Conversely, inducers of the CYP3A4 enzyme, such as rifampin, carbamazepine, and phenytoin, may reduce the efficacy of hydromorphone.
Patients with a history of substance abuse or addiction may be at increased risk of misuse or overdose with hydromorphone. Caution is advised when prescribing this medication to these individuals, and strategies to reduce the risk of addiction should be employed.
It is important to note that this is not an exhaustive list of all potential drug interactions. Prescribers should consult the full prescribing information for hydromorphone and review the patient's complete medication profile for potential drug interactions before prescribing this medication. Patients should be advised to report all medications they are taking, including over-the-counter drugs and herbal supplements, to their healthcare provider. If you have any questions or concerns regarding the use of Hydromorphone HCl 2 mg/ml Oral Liquid or its interactions with other medications, please reach out to us at Bayview Pharmacy for further assistance.
Hydromorphone HCl 2 mg/ml Oral Liquid is a potent opioid analgesic specifically designed for oral use. This medication works by binding to the mu-opioid receptors in the brain and spinal cord, which are part of the central nervous system. When Hydromorphone binds to these receptors, it alters the perception of and response to pain, providing relief to the patient. Additionally, it can produce a sense of well-being and euphoria, which may contribute to its pain-relieving effects.
The liquid formulation of Hydromorphone HCl is particularly beneficial for patients who have difficulty swallowing pills or tablets, such as those with dysphagia, or for situations where a rapid onset of pain relief is necessary. It is also ideal for pediatric and geriatric patients who may have trouble with solid dosage forms. The liquid form allows for flexible dosing, which can be precisely measured to ensure the patient receives the exact amount of medication required to manage their pain effectively.
Hydromorphone is used to treat moderate to severe pain conditions that are not adequately managed by other, less potent pain medications. It is often prescribed for acute pain following surgery, for cancer-related pain, or for other severe pain conditions where an opioid analgesic is appropriate. The 2 mg/ml concentration allows for titration of the dose to the individual needs of the patient, which is essential for achieving optimal pain control while minimizing side effects.
These can include respiratory depression, sedation, and hypotension, among others. Therefore, it is crucial that this medication is prescribed and monitored by a healthcare professional who is familiar with the patient's medical history and the proper use of opioid medications.
For those considering Hydromorphone HCl 2 mg/ml Oral Liquid for pain management, it is essential to use the medication exactly as prescribed and report any concerns or side effects to the healthcare provider immediately. If you have any questions or need further information about this formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to support you with expert advice and personalized care.
Hydromorphone HCl 2 mg/ml Oral Liquid is a prescription opioid pain medication designed for oral use. It is specifically prepared to deliver a measured dose of 2 milligrams of hydromorphone hydrochloride in each milliliter of liquid, used to treat moderate to severe pain in patients.
This medication should be taken exactly as prescribed by your doctor. Measure your dose with the provided dosing syringe or another accurate measuring device to ensure you are taking the correct amount. Do not use household spoons as they may not provide an accurate dose.
This liquid formulation is ideal for individuals who have difficulty swallowing pills, such as the pediatric and geriatric populations, or those who have medical conditions that make swallowing solid forms of medication difficult.
It's important to follow your doctor's instructions regarding food and beverage interactions. Some medications may be mixed with certain foods or liquids to make them tastier, but always confirm with your healthcare provider or pharmacist before doing so.
Store the medication at room temperature, away from light and moisture. Do not store it in the bathroom, and keep it out of the reach of children and pets. Check the product's specific storage requirements or ask your pharmacist for guidance.
If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and resume your usual dosing schedule. Do not double up on doses to make up for a missed one.
No, do not discontinue the use of this medication without consulting your doctor. Stopping hydromorphone suddenly can cause withdrawal symptoms, especially if you have been using it for a long period of time or in high doses.
Yes, hydromorphone can cause side effects including drowsiness, dizziness, constipation, nausea, and vomiting. If you experience any severe side effects, like difficulty breathing or signs of an allergic reaction, seek medical attention immediately.
No, consuming alcohol while taking hydromorphone can increase the risk of dangerous side effects or even death. It's important to avoid alcohol and any other central nervous system depressants while using this medication.
No, hydromorphone can impair your thinking and reactions. It is unsafe to drive or operate heavy machinery until you know how the medication affects you and are sure you can perform such activities safely.
You should discuss your entire medical history with your healthcare provider, including any history of substance abuse or addiction, other medications you are currently taking, and any other health conditions you might have. This information will help your provider determine if hydromorphone is safe and appropriate for you.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
This preparation is a controlled substance. Additional prescribing, refill, and shipping restrictions apply, and the states Bayview can dispense it to are narrower than for non-controlled preparations.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
